Dilok Klaisataporn Quality Stocks The SPDR S&P 500 ETF Trust (SPY) posted a 4.57% return in December, ending the year on a very strong note. Vanguard's Dividend Appreciation Index Fund ETF Shares (VIG) locked in a slightly lower gain of 4.13% last month. My watchlist outperformed both, posting a very strong gain of 9.52%. The final 2023 returns are 20.89% for my watchlist, 14.50% for VIG, and 26.18% for SPY. While SPY beat my watchlist this year, since inception, the watchlist remains dominant, outperfo ...

Cigna Group (NYSE:CI) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Ralph Giacobbe - SVP & Head, IR David Cordani - President, CEO & Chair Brian Evanko - EVP & CFO Eric Palmer - CEO, President & Director Conference Call Participants Lisa Gill - JPMorgan Chase & Co. Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America Merrill Lynch David Windley - Jefferies Scott Fidel - Stephens Inc. Stephen Baxter - Wells Fargo Securities Joshua Raskin - Nephron Research Gary T ...

A. Reinsurance Recoverables The majority of the Company's reinsurance recoverables resulted from acquisition and disposition transactions in which the underwriting company was not acquired. The Company bears the risk of loss if its reinsurers and retrocessionaires do not meet or are unable to meet their reinsurance obligations to the Company. The Company reviews its reinsurance arrangements and establishes reserves against the recoverables primarily for expected credit losses. 22 The Company's reinsurance r ...

The Cigna Group (NYSE:CI) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Ralph Giacobbe - Senior Vice President of Investor Relations David Cordani - Chairman and Chief Executive Officer Brian Evanko - Chief Financial Officer Eric Palmer - President and Chief Executive Officer, Evernorth Health Services Conference Call Participants Scott Fidel - Stephens A.J. Rice - Credit Suisse Justin Lake - Wolfe Research Lisa Gill - JPMorgan Kevin Fischbeck - Bank of America Josh Raskin ...

| --- | --- | --- | --- | |-------------------------------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | Connecting for a healthier future | | | | | T H E C I G N A G R O U P I N V E S T O R P R E S E N T A T I O N A U G U S T 3 , 2 0 2 3 | | | | CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 © 2023 The Cigna Group other key financial information Adjusted revenues ...

There have been no other material changes to other information presented in guarantees and contractual obligations set forth in our 2022 Form 10-K. The preparation of Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect reported amounts and related disclosures in the Consolidated Financial Statements. Management considers an accounting estimate to be critical if: 46 Management has discussed how critical accounting estimates are developed ...

The Cigna Group (NYSE:CI) Q1 2023 Earnings Conference Call May 5, 2023 8:30 AM ET Company Participants Ralph Giacobbe - SVP & Head of IR David Cordani - Chairman & CEO Brian Evanko - EVP & CFO Conference Call Participants Lisa Gill - J.P. Morgan Steven Valiquette - Barclays Bank Nathan Rich - Goldman Sachs Albert Rice - Crédit Suisse Justin Lake - Wolfe Research Erin Wright - Morgan Stanley Kevin Fischbeck - Bank of America Securities Gary Taylor - TD Cowen Stephen Baxter - Wells Fargo Securities Joshua Ras ...

Adjusted revenues is used by The Cigna Group's management because it permits analysis of trends in underlying revenue. The Company defines adjusted revenues as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Special items are matters that management believes are not representative of the underlying results of operations due ...

Pharmacy and other service costs increased 6%, reflecting higher specialty claims volume as well as inflation on, and higher sales of, branded drugs. Medical costs and other benefit expenses increased 9%, primarily reflecting an increased insured customer base (primarily within our Individual business) and trend in Cigna Healthcare, partially offset by the impact of the Chubb transaction. Interest expense and other increased 20%, primarily reflecting higher interest rates on our indebtedness and increased p ...

| --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...